Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dave Singh

Showing results (251-260 of 505) with videos related to

Pageof 51
Sort By:
British Journal of Clinical Pharmacology|May 22, 2024
Pharmacodynamics, pharmacokinetics and CYP3A4 interaction potential of the selective P2X3 receptor antagonist filapixant: A randomized multiple ascending-dose study in healthy young menChristian Friedrich, Dave Singh, Klaus Francke, et al.
Biomedicines|December 24, 2021
Red Blood Cell-Derived Iron Alters Macrophage Function in COPDJames M Baker, Molly Hammond, Josiah Dungwa, et al.
Biomarker Research|April 14, 2018
PI3K, p38 and JAK/STAT signalling in bronchial tissue from patients with asthma following allergen challengeThomas Southworth, Sarah Mason, Alan Bell, et al.
ERJ Open Research|April 26, 2021
Lung function improvements following inhaled indacaterol/glycopyrronium/mometasone furoate are independent of dosing time in asthma patients: a randomised trialJutta Beier, Henrik Watz, Zuzana Diamant, et al.
Expert Review of Respiratory Medicine|March 24, 2022
New insights into the optimal management of COPD: extracts from CHEST 2021 annual meeting (October 17-20, 2021)Jennifer Quint, Jukka Montonen, Dave Singh, et al.
Journal of Immunological Methods|November 11, 2021
The commutability of enzyme linked immunosorbent assays for the quantification of serum eosinophil-derived neurotoxin (EDN)Bert Rutten, Simon Young, Sarah Aldridge, et al.
American Journal of Respiratory and Critical Care Medicine|March 9, 2013
Predictors of objective cough frequency in chronic obstructive pulmonary diseaseHelen Sumner, Ashley Woodcock, Umme Kolsum, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 24, 2016
Neutral sphingomyelinase-2, acid sphingomyelinase, and ceramide levels in COPD patients compared to controlsSimon R Lea, Hannah J Metcalfe, Jonathan Plumb, et al.
ERJ Open Research|May 25, 2023
Comparison of the Asthma Control Questionnaire and patient diaries in uncontrolled asthmaDave Singh, Alberto Papi, Guy Brusselle, et al.
Respiratory Research|May 9, 2025
Step up to triple therapy versus switch to dual bronchodilator therapy in patients with COPD on an inhaled corticosteroid/long-acting β<sub>2</sub>-agonist: post-hoc analyses of KRONOSDave Singh, Mona Bafadhel, Niki Arya, et al.
Pageof 51

Showing results (251-260 of 505) with videos related to

Sort By:
Pageof 51
British Journal of Clinical Pharmacology|May 22, 2024
Pharmacodynamics, pharmacokinetics and CYP3A4 interaction potential of the selective P2X3 receptor antagonist filapixant: A randomized multiple ascending-dose study in healthy young menChristian Friedrich, Dave Singh, Klaus Francke, et al.
Biomedicines|December 24, 2021
Red Blood Cell-Derived Iron Alters Macrophage Function in COPDJames M Baker, Molly Hammond, Josiah Dungwa, et al.
Biomarker Research|April 14, 2018
PI3K, p38 and JAK/STAT signalling in bronchial tissue from patients with asthma following allergen challengeThomas Southworth, Sarah Mason, Alan Bell, et al.
ERJ Open Research|April 26, 2021
Lung function improvements following inhaled indacaterol/glycopyrronium/mometasone furoate are independent of dosing time in asthma patients: a randomised trialJutta Beier, Henrik Watz, Zuzana Diamant, et al.
Expert Review of Respiratory Medicine|March 24, 2022
New insights into the optimal management of COPD: extracts from CHEST 2021 annual meeting (October 17-20, 2021)Jennifer Quint, Jukka Montonen, Dave Singh, et al.
Journal of Immunological Methods|November 11, 2021
The commutability of enzyme linked immunosorbent assays for the quantification of serum eosinophil-derived neurotoxin (EDN)Bert Rutten, Simon Young, Sarah Aldridge, et al.
American Journal of Respiratory and Critical Care Medicine|March 9, 2013
Predictors of objective cough frequency in chronic obstructive pulmonary diseaseHelen Sumner, Ashley Woodcock, Umme Kolsum, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 24, 2016
Neutral sphingomyelinase-2, acid sphingomyelinase, and ceramide levels in COPD patients compared to controlsSimon R Lea, Hannah J Metcalfe, Jonathan Plumb, et al.
ERJ Open Research|May 25, 2023
Comparison of the Asthma Control Questionnaire and patient diaries in uncontrolled asthmaDave Singh, Alberto Papi, Guy Brusselle, et al.
Respiratory Research|May 9, 2025
Step up to triple therapy versus switch to dual bronchodilator therapy in patients with COPD on an inhaled corticosteroid/long-acting β<sub>2</sub>-agonist: post-hoc analyses of KRONOSDave Singh, Mona Bafadhel, Niki Arya, et al.
Pageof 51